CSL (ASX:CSL) share price up after AstraZeneca vaccine approved for use in Australia

The CSL Limited (ASX: CSL) share price is up by 2.73% today. The positive price movement comes on the heels of news the Australian government has approved use of its COVID-19 vaccine within the country.

At the time of writing, shares in the pharmaceutical giant are trading for $260.87 – up 2.44%. By comparison the S&P/ASX 200 Index (ASX: XJO) is up 0.66%.

Let’s take a closer at the government’s announcement.

CSL-made AstraZeneca vaccine will be used in Australia

The CSL share price is responding well to today’s news. The Therapeutic Goods Administration (TGA) announced late on Sunday it had approved use of the…